The host cell protein testing market is expected to grow at a CAGR of 5.7% by 2027. The host cell protein (HCP) testing industry will be fueled by a host of factors, including the advances in the biopharmaceutical sector along with the rise in R&D activities. The notable technical innovations in the HCP testing devices, with keen focus on elevating their quality and integrating more features, would be a favorable aspect for the global market.
The dramatic surge in several chronic disorders such diabetes and as cancer and the resultant increase in R&D efforts to explore more effective treatments should also contribute to the business growth. The International Agency for Research on Cancer (IARC) reveals that the worldwide prevalence of cancer had touched close to 20.3 million cases in 2020, while claiming around 11 million lives. In addition, the American Cancer Society confirms that by 2040, the total cancer cases should reach 28.5 million with 18.3 million deaths.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10651
Most of the vendors are focused on product and technological innovations and obtaining approval from authoritative bodies to gain higher penetration in the host cell protein testing market. Moreover, the players are involved in strategic agreements, as well as joint ventures to foster their business standing in the worldwide market.
Regional Analysis
North America is likely to dominate the host cell protein testing market, owing to increasing investments in R&D, the presence of key companies, and developed healthcare infrastructure in the region. For instance, in 2020, the National Institutes of Health (NIH) received a funding of USD 42 billion, which has increased by 7% compared to 2019.
Europe is likely to account for a significant share in the host cell protein testing market due to supportive government initiations and rising R&D investments. The launch of new products by the market players is expected to further flourish the market growth in Europe. For instance, in September 2019, Amsbio LLC (UK) launched new HCP detection kits specialized in detecting HCP at any stage of the drug development process.
Asia-Pacific is projected to be the fastest-growing regional market during the forecast period due tothe high prevalence of chronic diseases like cancer and emerging economies. For instance, according to the World Cancer Research Fund (WCRF), in 2018, Australia had the highest cancer rate for both sexes at 468.0 per 100,000 individuals, which is boosting R&D efforts to find new viable drugs driving the HCP testing market.
Furthermore, the growth of the market in the Rest of the World is attributed to improving healthcare facilities and supportive government regulations to bring more advanced technologies into the region.
Segmentation
The global host cell protein testing market has been segmented into type and end user.
By type, the market has been segmented into PCR-based assays, ELISA-based assays, and others. The ELISA-based assays segment is expected to hold the largest share of the market in 2020 as it is considered the gold standard for HCP testing.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/host-cell-protein-testing-market-10651
Based on end users, the market has been segmented into Contract Research Organizations (CROs), biopharmaceutical companies, and others. The biopharmaceutical companies segment held the largest segment share in 2020because of the extensive R&D efforts and company funding to develop new therapeutics and utilization of HCP testing in the process.
Key Players
Cygnus Technologies Inc. (US), BioGenes GmbH (Germany), Cytiva (US), Cisbio Bioassays (France), Thermo Fisher Scientific (US), Charles River (US), ForteBio (Pall) (US), Molecular Devices (US), Bio-Rad Laboratories (US), are the most significant host cell protein testing device and solutions developers in the global industry.
Browse Related Reports at:
Global Neuromodulation Devices Market Research Report- Forecast To 2027
India CRO Market Research Report- Global Forecast to 2023
Eyelashes Enhancing Agents Market Research Report – Global Forecast till 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com